MapLight Therapeutics MPLT
NASDAQ MPLT
$8.25 +0.09 (+1.10%)
At close: Oct 22, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) Cash from Operations (2024 - 2025)

Updated

MapLight Therapeutics (MPLT) recorded Cash from Operations of -$46.83 million in Q4 2025, compared with -$21.49 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) Cash from Operations (2024 - 2025) Analysis & Trends

For FY2025, MapLight Therapeutics reported Cash from Operations of -$138.14 million.

  • Across earlier years, Cash from Operations came in at -$78.82 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 7.72 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.44 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 2.87 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.57 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 835.00 Mn
10 MapLight Therapeutics 374.85 Mn 70.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -46.83 Mn
Sep 30, 2025 -31.79 Mn
Dec 31, 2024 -21.49 Mn
API Access

MapLight Therapeutics Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=MPLT&period=max&api_key=YOUR_API_KEY